Marla Dubinsky

3.7k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Marla Dubinsky is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Marla Dubinsky has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 14 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Marla Dubinsky's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (7 papers). Marla Dubinsky is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (7 papers). Marla Dubinsky collaborates with scholars based in United States, Canada and United Kingdom. Marla Dubinsky's co-authors include Frank M. Ruemmele, Jeffrey S. Hyams, James Markowitz, Anne M. Griffiths, Richard K. Russell, Thomas D. Walters, David C. Wilson, Mary Sherlock, Arie Levine and Dan Turner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Marla Dubinsky

14 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pediatric modification of the Montreal classification for inflammatory bowel disease

2010 1.1k citations Arie Levine, Anne M. Griffiths et al. Inflammatory Bowel Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marla Dubinsky United States	9	1.5k	1.1k	585	496	163	19	1.8k
Mary Sherlock Canada	11	1.4k 0.9×	955 0.9×	761 1.3×	345 0.7×	129 0.8×	35	1.8k
John Fell United Kingdom	18	1.5k 1.0×	1.1k 1.0×	818 1.4×	374 0.8×	184 1.1×	29	2.0k
Kathleen G. Lomax United States	17	1.6k 1.1×	1.3k 1.2×	660 1.1×	342 0.7×	211 1.3×	59	2.0k
Gwénola Vernier-Massouille France	14	1.5k 1.0×	1.2k 1.1×	624 1.1×	285 0.6×	119 0.7×	22	1.7k
Julien Branche France	18	1.1k 0.7×	857 0.8×	805 1.4×	295 0.6×	95 0.6×	46	1.8k
Benjamin Pariente France	23	1.4k 1.0×	1.1k 1.0×	665 1.1×	420 0.8×	67 0.4×	88	1.8k
A. Cassinotti Italy	24	1.2k 0.8×	987 0.9×	497 0.8×	394 0.8×	118 0.7×	59	2.0k
D. H. Present United States	6	1.4k 1.0×	1.1k 1.1×	505 0.9×	236 0.5×	96 0.6×	11	1.7k
Mathurin Fumery France	15	1.1k 0.7×	890 0.8×	458 0.8×	157 0.3×	62 0.4×	28	1.3k
Michael F. Picco United States	25	1.4k 1.0×	1.1k 1.0×	877 1.5×	213 0.4×	57 0.3×	142	2.2k

Countries citing papers authored by Marla Dubinsky

Since Specialization

Citations

This map shows the geographic impact of Marla Dubinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla Dubinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla Dubinsky more than expected).

Fields of papers citing papers by Marla Dubinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla Dubinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla Dubinsky. The network helps show where Marla Dubinsky may publish in the future.

Co-authorship network of co-authors of Marla Dubinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Marla Dubinsky. A scholar is included among the top collaborators of Marla Dubinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla Dubinsky. Marla Dubinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dolinger, Michael T., Brad D. Constant, Zi Wang, et al.. (2025). Ustekinumab is safe and effective in pediatric patients with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. 80(4). 653–663.

Panaccione, Remo, Alison Potts Bleakman, Stefan Schreiber, et al.. (2025). US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn’s Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey. Crohn s & Colitis 360. 7(2). otaf011–otaf011. 1 indexed citations

Rubin, David T., Alison Potts Bleakman, Simon Travis, et al.. (2025). Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn’s Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey. Advances in Therapy. 42(9). 4510–4526.

Hunter, Theresa, et al.. (2024). Patient perception of bowel urgency and remission in moderately to severely active Crohn’s disease or ulcerative colitis: a qualitative study. Journal of Patient-Reported Outcomes. 8(1). 130–130. 1 indexed citations

Feagan, Brian G., Jean–Frédéric Colombel, Remo Panaccione, et al.. (2024). Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease. SHILAP Revista de lepidopterología. 4(1). 100544–100544. 1 indexed citations

Rosh, Joel R., Dan Turner, Jeffrey S. Hyams, et al.. (2024). Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease. Journal of Crohn s and Colitis. 18(8). 1250–1260.

Dubinsky, Marla, Aisha Vadhariya, Frédérick Durand, et al.. (2024). The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn’s Disease. Advances in Therapy. 42(2). 1044–1060. 2 indexed citations

Yarur, Andrés, Snehal Naik, Poonam Beniwal‐Patel, et al.. (2019). Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 64(6). 1651–1659. 36 indexed citations

Stidham, Ryan W., Chunyan Liu, Mi‐Ok Kim, et al.. (2018). Association Between Plasma Level of Collagen Type III Alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 17(9). 1799–1806. 18 indexed citations

10.

Lasch, Karen, et al.. (2016). Gastroenterologists’ Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey. Advances in Therapy. 33(10). 1715–1727. 7 indexed citations

11.

Dubinsky, Marla, Jeffrey S. Hyams, Samantha Eichner, et al.. (2016). Su1918 Efficacy and Safety of Adalimumab in Pediatric Patients With Crohn's Disease Aged 10 Years and Younger: Subanalysis of IMAgINE 1. Gastroenterology. 150(4). S588–S588.

12.

Hyams, Jeffrey S., Joel R. Rosh, James Markowitz, et al.. (2015). Mo1208 Effect of Adalimumab on Clinical Laboratory Parameters in Pediatric Crohn's Disease Patients From IMAgINE 1. Gastroenterology. 148(4). S–638.

13.

Rabizadeh, Shervin & Marla Dubinsky. (2013). Update in Pediatric Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America. 39(4). 789–799. 26 indexed citations

14.

Hyams, Jeffrey S., Anne M. Griffiths, James Markowitz, et al.. (2012). Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children. Gastroenterology. 143(2). 365–374.e2. 214 indexed citations

15.

Levine, Arie, Anne M. Griffiths, James Markowitz, et al.. (2010). Pediatric modification of the Montreal classification for inflammatory bowel disease. Inflammatory Bowel Diseases. 17(6). 1314–1321. 1054 indexed citations breakdown →

16.

McGovern, Dermot, Jerome I. Rotter, Ling Mei, et al.. (2009). Genetic epistasis of IL23/IL17 pathway genes in Crohnʼs disease. Inflammatory Bowel Diseases. 15(6). 883–889. 60 indexed citations

17.

Han, Xiaonan, Kanji Uchida, Ingrid Jurickova, et al.. (2008). Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease. Gastroenterology. 136(4). 1261–1271.e3. 93 indexed citations

18.

Cuffari, Carmen, Marla Dubinsky, Anil Darbari, Laureen Sena, & Robert N. Baldassano. (2005). Crohnʼs Jejunoileitis: The Pediatricianʼs Perspective on Diagnosis and Management. Inflammatory Bowel Diseases. 11(7). 696–704. 20 indexed citations

19.

Ruemmele, Frank M., et al.. (1998). Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 115(4). 822–829. 280 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact